Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial.

Bioengineering (Basel) · 2026 · PMC13403406 · PMID 42510471

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although CB-PRP demonstrated numerically higher EQ-VAS and KOOS values at several follow-up visits, these differences were modest and generally failed to reach statistical significance, with the exception of a transient advantage in KOOS at 6 months.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.